Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Regenerative Therapy|August 12, 2024
Evaluation of cleaning methods for change-over after the processing of cell products to avoid cross-contamination riskMitsuru Mizuno, Kouichirou Yori, Toshikazu Takeuchi, et al.
Frontiers in Microbiology|January 23, 2024
Clinical significance of anti-Epstein-Barr virus antibodies in systemic chronic active Epstein-Barr virus diseaseMiwako Nishio, Minori Saito, Mayumi Yoshimori, et al.
International Journal of Hematology|July 25, 2025
Expression profiling of Epstein-Barr virus-derived microRNA in systemic chronic active EBV diseaseMayumi Yoshimori, Miwako Nishio, Ayaka Ohashi, et al.
Frontiers in Microbiology|April 25, 2022
The Plasma Level of Interleukin-1β Can Be a Biomarker of Angiopathy in Systemic Chronic Active Epstein-Barr Virus InfectionAyaka Ohashi, Yu Uemura, Mayumi Yoshimori, et al.
Blood Advances|March 31, 2021
Antineoplastic and anti-inflammatory effects of bortezomib on systemic chronic active EBV infectionMayumi Yoshimori, Haruna Shibayama, Ken-Ichi Imadome, et al.
Drug Discoveries & Therapeutics|February 21, 2024
Inhibitory effects of kaempferol, quercetin and luteolin on the replication of human parainfluenza virus type 2 in vitroKae Sakai-Sugino, Jun Uematsu, Hidetaka Yamamoto, et al.
Drug Discoveries & Therapeutics|January 21, 2020
Inhibitions of human parainfluenza virus type 2 replication by ribavirin and mycophenolate mofetil are restored by guanosine and S-(4-nitrobenzyl)-6-thioinosineJun Uematsu, Kae Sakai-Sugino, Sahoko Kihira-Nakanishi, et al.
Pageof 3